Oncotelic Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Oncotelic Therapeutics, Inc. (OTLC) reported Adjustments to Additional Paid in Capital, Warrant Issued of $328.58 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-04-15
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $368.38K, a 81.80% decline year-over-year.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $2.91M, a 1644.15% increase year-over-year.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $2.02M.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-03-31 was $166.57K.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $328.58K, a 88.69% decline from fiscal 2022.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $2.91M, a 383.44% increase from fiscal 2021.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $600.97K, a 40.62% increase from fiscal 2020.
- Oncotelic Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $427.37K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2023-12-31 | $328.58K 10-K · filed 2025-04-15 | ||
| 2022-12-31 | $2.91M 10-K/A · filed 2023-04-20 | ||
| 2022-06-30 | $368.38K 10-Q · filed 2023-11-14 | $3.27M derived: sum of 2 quarters · filed 2023-11-14 | |
| 2022-03-31 | $2.91M 10-Q · filed 2023-11-14 | ||
| 2021-12-31 | $600.97K 10-K/A · filed 2023-04-20 | ||
| 2021-06-30 | $2.02M 10-Q · filed 2022-11-18 | $2.19M derived: sum of 2 quarters · filed 2022-11-18 | |
| 2021-03-31 | $166.57K 10-Q · filed 2022-11-18 | ||
| 2020-12-31 | $427.37K 10-K · filed 2021-04-15 | ||
| 2020-09-30 | $365.43K 10-Q · filed 2021-11-22 | ||
| 2014-12-31 | $9.51M 10-K · filed 2016-03-25 |